| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d679076421e82e397de2bd1c4167bda |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2004-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2eed3810ba3ecb1c3aa526e8089ec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387dc4ff0a5c70dbf49313b87189a53f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a948590cd66c437bee4cadede7144f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ad9a6a9da1e980c64388d38d417e643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c523f1181573da260bc952be3abbe61e |
| publicationDate |
2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7192927-B2 |
| titleOfInvention |
Peptides |
| abstract |
Isolated peptides that are fragments of protein products arising from frameshift mutations in genes associated with cancer are disclosed. The isolated peptides of the invention are capable of eliciting T cell immunity against cells harboring genes with such frameshift mutations. Cancer vaccines and therapeutically effective compositions containing the peptides of the invention are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008069831-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015045291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7632511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105721-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8728489-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9732131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8821892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008107671-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8388980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8007816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010150963-A1 |
| priorityDate |
1998-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |